Edition:
United States

Assembly Biosciences Inc (ASMB.OQ)

ASMB.OQ on NASDAQ Stock Exchange Capital Market

35.07USD
2:00pm EDT
Change (% chg)

$0.66 (+1.92%)
Prev Close
$34.41
Open
$34.42
Day's High
$36.58
Day's Low
$34.42
Volume
53,002
Avg. Vol
74,799
52-wk High
$66.89
52-wk Low
$27.00

Chart for

About

Assembly Biosciences, Inc. is a biotechnology company. The Company is engaged in developing two platform programs, such as a class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection, and a class of oral synthetic live therapeutics, which are designed to restore health to a dysbiotic microbiome. It has... (more)

Overall

Beta: 0.83
Market Cap(Mil.): $875.61
Shares Outstanding(Mil.): 25.45
Dividend: --
Yield (%): --

Financials

  ASMB.OQ Industry Sector
P/E (TTM): -- 29.91 32.14
EPS (TTM): -3.42 -- --
ROI: -55.76 12.97 12.66
ROE: -91.92 14.97 14.84

BRIEF-Assembly Biosciences Q1 Loss Per Share $0.80

* ASSEMBLY BIOSCIENCES ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

May 07 2018

BRIEF-Assembly Biosciences Presents Positive Interim Data from Phase 1a and 1b Studies of ABI-H0731 in HBV Patients

* ASSEMBLY BIOSCIENCES PRESENTS POSITIVE INTERIM DATA FROM PHASE 1A AND 1B STUDIES OF ABI-H0731 IN HBV PATIENTS IN A LATE-BREAKER SESSION AT THE EASL CONFERENCE

Apr 12 2018

Competitors

  Price Chg
Kyowa Hakko Kirin Co Ltd (4151.T) ¥2,079 +66.00

Earnings vs. Estimates